Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease (Q87457713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Joanna Suszyńska-Zajczyk

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marta Sikora

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

17 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

200-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Paraoxonase 1 and homocysteine metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Paraoxonase 1 in chronic kidney failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Increased plasma protein homocysteinylation in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

The treatment of hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Paraoxonase 1 protects against protein N-homocysteinylation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Methionine-induced hyperhomocysteinemia and bleomycin hydrolase deficiency alter the expression of mouse kidney proteins involved in renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Bleomycin hydrolase and hyperhomocysteinemia modulate the expression of mouse proteins involved in liver homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Molecular pathways and crosstalk characterizing the cardiorenal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Dyslipidemias in patients who have chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

The compositional abnormalities of lipoproteins in diabetic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Progression of secondary hyperparathyroidism involves deregulation of genes related to DNA and RNA stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.07.011

10.1016/J.YMGME.2014.07.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25069821%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference